Utility of CC7 Transfer in Stroke Subtypes
Recruiting
N/A
Interventional Study
Stroke, Ischemic
Stroke Hemorrhagic
Spastic Hemiparesis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 65
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 95 (estimated)
- Sponsor
- Dartmouth-Hitchcock Medical Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this study is to evaluate the limb functional improvement after contralateral C7 root transfer in stroke patients.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* History of ischemic or hemorrhagic stroke with resultant arm paresis that has ceased to improve within 1-5 years of rehabilitation.
* baseline Fugl-Meyer score below 33
Exclusion Criteria:
* pregnancy
Contacts